Zhuo Yu

3.6k total citations · 2 hit papers
81 papers, 2.7k citations indexed

About

Zhuo Yu is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Zhuo Yu has authored 81 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 21 papers in Epidemiology and 21 papers in Immunology. Recurrent topics in Zhuo Yu's work include Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (10 papers) and Liver Disease Diagnosis and Treatment (10 papers). Zhuo Yu is often cited by papers focused on Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (10 papers) and Liver Disease Diagnosis and Treatment (10 papers). Zhuo Yu collaborates with scholars based in China, United States and Hong Kong. Zhuo Yu's co-authors include Jianfeng Guo, Leaf Huang, Yueqiu Gao, Mengying Hu, Yifang Zou, Dandan Sun, Song Liu, Manisit Das, Shulan Han and Hao Yang and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Zhuo Yu

77 papers receiving 2.7k citations

Hit Papers

Icaritin Exacerbates Mitophagy and Synergizes with Doxoru... 2020 2026 2022 2024 2020 2023 100 200 300

Peers

Zhuo Yu
Nan Xu China
Frank Jacobs Belgium
Srinivas V. Koduru United States
Zhuo Yu
Citations per year, relative to Zhuo Yu Zhuo Yu (= 1×) peers Yueqiu Gao

Countries citing papers authored by Zhuo Yu

Since Specialization
Citations

This map shows the geographic impact of Zhuo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuo Yu more than expected).

Fields of papers citing papers by Zhuo Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuo Yu. The network helps show where Zhuo Yu may publish in the future.

Co-authorship network of co-authors of Zhuo Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuo Yu. A scholar is included among the top collaborators of Zhuo Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuo Yu. Zhuo Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yutong, Dong Li, Junjun Chen, et al.. (2025). Nanodelivery of panobinostat induces cell cycle arrest and apoptosis to suppress hepatocellular carcinoma growth in mice. Materials Today Bio. 35. 102418–102418.
2.
Chen, Junjun, Lingzhi Wang, Leilei Yang, et al.. (2024). cGAS-STING activation by nanodelivery of teniposide achieves colorectal cancer chemo-immunotherapy. European Polymer Journal. 219. 113379–113379. 5 indexed citations
3.
Wang, Lingzhi, Zhuo Yu, Jihong Zhang, & Jianfeng Guo. (2024). Nanoformulations of chemotherapeutic activators of the cGAS–STING pathway in tumor chemoimmunotherapy. Drug Discovery Today. 29(3). 103892–103892. 7 indexed citations
4.
Lu, Xiaona, Yuyao Li, Yue Li, et al.. (2024). Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling. Phytomedicine. 126. 155395–155395. 13 indexed citations
5.
Wang, Lingzhi, Zhuo Li, Yutong Li, et al.. (2024). Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy. Biomaterials. 313. 122766–122766. 19 indexed citations
6.
Zhang, Xuemei, et al.. (2024). Bile Acids and Liver Cancer: Molecular Mechanism and Therapeutic Prospects. Pharmaceuticals. 17(9). 1142–1142. 2 indexed citations
8.
Han, Shulan, Xueying Bao, Yifang Zou, et al.. (2023). d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma. Science Advances. 9(29). eadg2697–eadg2697. 178 indexed citations breakdown →
9.
Yu, Zhuo, Yifang Zou, Shulan Han, et al.. (2023). Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity. Fundamental Research. 5(3). 1298–1312. 6 indexed citations
12.
Li, Yuyao, Yue Li, Jinghao Zhang, et al.. (2022). Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 15 indexed citations
13.
Liu, Song, Hao Yang, Di Liang, et al.. (2022). A chlorogenic acid-loaded hyaluronic acid-based hydrogel facilitates anti-inflammatory and pro-healing effects for diabetic wounds. Journal of Drug Delivery Science and Technology. 70. 103232–103232. 26 indexed citations
14.
Yang, Hao, Song Liu, Leilei Yang, et al.. (2021). Modulation of macrophages by a paeoniflorin-loaded hyaluronic acid-based hydrogel promotes diabetic wound healing. Materials Today Bio. 12. 100139–100139. 112 indexed citations
15.
Sun, Dandan, Yifang Zou, Song Liu, et al.. (2021). A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. Acta Pharmaceutica Sinica B. 12(1). 378–393. 152 indexed citations
16.
Yang, Hao, Song Liu, Yifang Zou, et al.. (2020). Role of Hyaluronic Acids and Potential as Regenerative Biomaterials in Wound Healing. ACS Applied Bio Materials. 4(1). 311–324. 84 indexed citations
17.
Sun, Dandan, Jian Zhang, Limei Wang, et al.. (2020). Nanodelivery of immunogenic cell death-inducers for cancer immunotherapy. Drug Discovery Today. 26(3). 651–662. 30 indexed citations
18.
Zhang, Jinghao, Chao Zheng, Xiaojun Zhu, et al.. (2019). Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2019. 1–6. 5 indexed citations
19.
Ji, Longshan, Xin Zhang, Zhenhua Zhou, et al.. (2019). Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients. Journal of Immunology Research. 2019. 1–10. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026